Skip to content
+49 3371 6199600info@celltrend.deIm Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Contact
  • German
  • English
topbar - English
Search:
Suche
CellTrend Luckenwalde
Auftragsforschung, Antikörperdiagnostik
CellTrend LuckenwaldeCellTrend Luckenwalde
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS–CFS/ME–SFN-Long Covid
    • Information for patients
  • ELISA
    • AT1R-Antibody ELISA
      • Product information
      • Transplantation
      • Systemic sclerosis
      • Literature
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research
  • Ordering ELISA Kits
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS–CFS/ME–SFN-Long Covid
    • Information for patients
  • ELISA
    • AT1R-Antibody ELISA
      • Product information
      • Transplantation
      • Systemic sclerosis
      • Literature
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research
  • Ordering ELISA Kits

Daily Archives: 5. May 2025

You are here:
  1. Home
  2. 2025
  3. May
  4. 05

New findings of Autoantibodies targeting GPCR in Sjögren´s Syndrome

NewsBy celltrend celltrend5. May 2025

The serum samples of over 300 patients with primary Sjögren´s Syndrome (pSS) were investigate and compared with 50 healthy controls. CellTrend GmbH measured the IgG autoantibodies by ELISAs. The results showed significantly increased antibodies against M1, M2, M3, M4, M5 and CXCR3. The most abundant markers were anti-M2 and anti-CXCR3. Furthermore the presence of several…

+49 3371 6199600 info@celltrend.de Im Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Data protection declaration
  • Imprint
bottombar - English

FacebookInstagram

Go to Top
Um unsere Webseite für Sie optimal zu gestalten und fortlaufend zu verbessern, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie deren Verwendung zu. Weitere Informationen erhalten Sie in unserer DatenschutzerklärungOK